Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
Titel:
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
Auteur:
Raadsen, Matthijs P Dahlke, Christine Fathi, Anahita Hardtke, Svenja Klüver, Michael Krähling, Verena Gerresheim, Gesche K Mayer, Leonie Mykytyn, Anna Z Weskamm, Leonie M Zoran, Tamara van Gorp, Eric C M Sutter, Gerd Becker, Stephan Haagmans, Bart L Addo, Marylyn M